{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:56:11Z","timestamp":1790283371143,"version":"4.1.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The autoimmune pathogenesis of type 1 diabetes (T1D) involves cellular infiltration from innate and adaptive immune subsets into the islets of Langerhans within the pancreas; however, the direct cytotoxic killing of insulin-producing \u03b2-cells is thought to be mediated primarily by antigen-specific CD8<jats:sup>+<\/jats:sup> T cells. Despite this direct pathogenic role, key aspects of their receptor specificity and function remain uncharacterized, in part, due to their low precursor frequency in peripheral blood. The concept of engineering human T cell specificity, using T cell receptor (TCR) and chimeric antigen receptor (CAR)-based approaches, has been demonstrated to improve adoptive cell therapies for cancer, but has yet to be extensively employed for modeling and treating autoimmunity. To address this limitation, we sought to combine targeted genome editing of the endogenous TCR\u03b1 chain gene (<jats:italic>TRAC<\/jats:italic>) via CRISPR\/Cas9 in combination with lentiviral vector (LV)-mediated TCR gene transfer into primary human CD8<jats:sup>+<\/jats:sup> T cells. We observed that knockout (KO) of endogenous <jats:italic>TRAC<\/jats:italic> enhanced <jats:italic>de novo<\/jats:italic> TCR pairing, which permitted increased peptide:MHC-dextramer staining. Moreover, <jats:italic>TRAC<\/jats:italic> KO and TCR gene transfer increased markers of activation and effector function following activation, including granzyme B and interferon-\u03b3 production. Importantly, we observed increased cytotoxicity toward an HLA-A*0201<jats:sup>+<\/jats:sup> human \u03b2-cell line by HLA-A*02:01 restricted CD8<jats:sup>+<\/jats:sup> T cells engineered to recognize islet-specific glucose-6-phosphatase catalytic subunit (IGRP). These data support the notion of altering the specificity of primary human T cells for mechanistic analyses of autoreactive antigen-specific CD8<jats:sup>+<\/jats:sup> T cells and are expected to facilitate downstream cellular therapeutics to achieve tolerance induction through the generation of antigen-specific regulatory T cells.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1142648","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T14:00:48Z","timestamp":1685455248000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8+ T cells"],"prefix":"10.3389","volume":"14","author":[{"given":"Leeana D.","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-I","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Arnoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Posgai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton E.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Brusko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13349","article-title":"Islet\u2013immune interactions in type 1 diabetes: the nexus of beta cell destruction","volume":"198","author":"Peters","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301480","article-title":"Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice","volume":"191","author":"Baker","year":"2013","journal-title":"J Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1113954108","article-title":"Specificity and detection of insulin-reactive CD4 +T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse","volume":"108","author":"Crawford","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0332","article-title":"In vivo Cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice","volume":"56","author":"Jarchum","year":"2007","journal-title":"Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.01.015","article-title":"Identification of novel IGRP epitopes targeted in type 1 diabetes patients","volume":"127","author":"Jarchum","year":"2008","journal-title":"Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12465","article-title":"Generation of \u03b2 cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice","volume":"179","author":"Babad","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2005.02168.x","article-title":"The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity","volume":"115","author":"Kemp","year":"2005","journal-title":"Immunology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102417","article-title":"Innate inflammation drives NK cell activation to impair treg activity","volume":"108","author":"Dean","year":"2020","journal-title":"J Autoimmun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/db17-0106","article-title":"Type 1 interferons potentiate human cd8+ t-cell cytotoxicity through a stat4-and granzyme b-dependent pathway","volume":"66","author":"Newby","year":"2017","journal-title":"Diabetes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.737276","article-title":"Use of induced pluripotent stem cells to build isogenic systems and investigate type 1 diabetes","volume":"12","author":"Armitage","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88242","article-title":"Tissue distribution and clonal diversity of the T and b cell repertoire in type 1 diabetes","volume":"1","author":"Seay","year":"2016","journal-title":"JCI Insight"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2107208118","article-title":"Human islet T cells are highly reactive to preproinsulin in type 1 diabetes","volume":"118","author":"Anderson","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nm.4203","article-title":"Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes","volume":"22","author":"Babon","year":"2016","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00421","article-title":"Age at seroconversion, HLA genotype, and specificity of autoantibodies in progression of islet autoimmunity in childhood","volume":"104","author":"Bauer","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0238","article-title":"Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the teddy study","volume":"40","author":"Krischer","year":"2017","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-020-00195-9","article-title":"Genetic and environmental determinants of human TCR repertoire diversity","volume":"17","author":"Krishna","year":"2020","journal-title":"Immun Ageing"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2021.665637","article-title":"Age and CMV-infection jointly affect the EBV-specific CD8+ T-cell repertoire","volume":"2","author":"Lanfermeijer","year":"2021","journal-title":"Front Aging"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200818","article-title":"Heterogeneity of circulating CD8 T-cells specific to islet, neo-antigen and virus in patients with type 1 diabetes mellitus","volume":"13","author":"Laban","year":"2018","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3986","article-title":"Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond","volume":"67","author":"Cohen","year":"2007","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science (1979)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0066","article-title":"Identification of novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives","volume":"55","author":"Standifer","year":"2006","journal-title":"Diabetes"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01313","article-title":"Avidity and bystander suppressive capacity of human regulatory T cells expressing de novo autoreactive T-cell receptors in type 1 diabetes","volume":"26","author":"Yeh","year":"2017","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000708","article-title":"Overexpression of the PTPN22 autoimmune risk variant LYP-620W fails to restrain human CD4 + T cell activation","volume":"207","author":"Perry","year":"2021","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171626","article-title":"Optimized RNP transfection for highly efficient CRI SPR\/Cas9-mediated gene knockout in primary T cells","volume":"215","author":"Seki","year":"2018","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020617","article-title":"Role of the mitochondria in immune-mediated apoptotic death of the human pancreatic \u03b2 cell line \u03b2Lox5","volume":"6","author":"Lightfoot","year":"2011","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.4.2186","article-title":"Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR\u03b1\u03b2 genes into primary human T lymphocytes","volume":"170","author":"Schaft","year":"2003","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100061","article-title":"Negative selection of human T cells recognizing a naturally-expressed tissue-restricted antigen in the human thymus","volume":"3","author":"Madley","year":"2020","journal-title":"J Transl Autoimmun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.04.011","article-title":"The autoimmunity-associated gene CLEC16A modulates thymic epithelial cell autophagy and alters T cell selection","volume":"42","author":"Schuster","year":"2015","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071720","article-title":"The quest for the best: how TCR affinity, avidity, and functional avidity affect TCR-engineered T-cell antitumor responses","volume":"9","author":"Campillo-Davo","year":"2020","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1005802107","article-title":"Mixed T cell receptor dimers harbor potentially harmful neoreactivity","volume":"107","author":"van Loenen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1221609110","article-title":"T-Cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy","volume":"110","author":"Zhong","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202104093","article-title":"Signal strength controls the rate of polarization within ctls during killing","volume":"220","author":"Frazer","year":"2021","journal-title":"J Cell Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35449","article-title":"CTLs are targeted to kill \u03b2 cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope","volume":"118","author":"Skowera","year":"2008","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501083","article-title":"The quantity of autocrine IL-2 governs the expansion potential of CD8 + T cells","volume":"195","author":"Redeker","year":"2015","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686439","article-title":"Precision engineering of an anti-HLA-A2 chimeric antigen receptor in regulatory T cells for transplant immune tolerance","volume":"12","author":"Muller","year":"2021","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12339","article-title":"Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells","volume":"177","author":"Dolton","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M700976200","article-title":"Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties","volume":"282","author":"Laugel","year":"2007","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh340","article-title":"Loss of CD8 and TCR binding to class I MHC ligands following T cell activation","volume":"17","author":"Kao","year":"2005","journal-title":"Int Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.289488","article-title":"A single autoimmune T cell receptor recognizes more than a million different peptides","volume":"287","author":"Wooldridge","year":"2012","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2007.00849.x","article-title":"Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules","volume":"70","author":"Hansen","year":"2007","journal-title":"Tissue Antigens"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.881525","article-title":"The foundation for engineering a pancreatic islet niche","volume":"13","author":"Patel","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aao4013","article-title":"Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors","volume":"3","author":"Culina","year":"2018","journal-title":"Sci Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aai7793","article-title":"Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes","volume":"1","author":"Long","year":"2016","journal-title":"Sci Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2337\/db17-1390","article-title":"Detection and characterization of CD8+ autoreactive memory stem T cells in patients with type 1 diabetes","volume":"67","author":"Vignali","year":"2018","journal-title":"Diabetes"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0633-5","article-title":"Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes","volume":"21","author":"Abdelsamed","year":"2020","journal-title":"Nat Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809818106","article-title":"High antigen levels are the cause of T cell exhaustion during chronic viral infection","volume":"106","author":"Mueller","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.18609\/cgti.2018.042","article-title":"Clinical applications of regulatory T cells in adoptive cell therapies","volume":"4","author":"Marshall","year":"2018","journal-title":"Cell Gene Ther Insights"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147474","article-title":"The effect of low-dose IL-2 and treg adoptive cell therapy in patients with type 1 diabetes","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700156","article-title":"Cutting edge: low-affinity TCRs support regulatory T cell function in autoimmunity","volume":"200","author":"Sprouse","year":"2018","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-020-00665-4","article-title":"CRISPR\/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells","volume":"21","author":"Kamali","year":"2021","journal-title":"BMC Biotechnol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100374","article-title":"Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy","volume":"2","author":"M\u00fcller","year":"2021","journal-title":"Cell Rep Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of haematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1710415114","article-title":"Type 1 diabetes induction in humanized mice","volume":"114","author":"Tan","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4551-0","article-title":"A type 1 diabetes genetic risk score can discriminate monogenic autoimmunity with diabetes from early-onset clustering of polygenic autoimmunity with diabetes","volume":"61","author":"Johnson","year":"2018","journal-title":"Diabetologia"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1142648\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T14:00:52Z","timestamp":1685455252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1142648\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2023.1142648"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1142648","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"article-number":"1142648"}}